Divi's Laboratories Ltd DIVISLAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 3,843.80
- Day Range
- INR 3,836.05–4,039.00
- 52-Week Range
- INR 3,051.00–4,074.40
- Bid/Ask
- INR 4,016.35 / INR 4,035.00
- Market Cap
- INR 1.07 Tril
- Volume/Avg
- 1.2 Mil / 533,486
Key Statistics
- Price/Earnings (Normalized)
- 75.89
- Price/Sales
- 14.42
- Dividend Yield (Trailing)
- 0.78%
- Dividend Yield (Forward)
- 0.78%
- Total Yield
- 0.75%
Company Profile
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 16,911
- Website
- https://www.divislabs.com
Comparables
Valuation
|
Metric
|
DIVISLAB
|
TORNTPHARM
|
533573
|
|---|---|---|---|
Price/Earnings (Normalized) | 75.89 | 62.96 | 32.90 |
Price/Book Value | 8.41 | 13.58 | 4.13 |
Price/Sales | 14.42 | 8.82 | 3.10 |
Price/Cash Flow | 69.24 | 39.43 | 23.86 |
Price/Earnings
DIVISLAB
TORNTPHARM
533573
Financial Strength
|
Metric
|
DIVISLAB
|
TORNTPHARM
|
533573
|
|---|---|---|---|
Quick Ratio | 5.54 | 0.55 | 0.72 |
Current Ratio | 8.79 | 1.08 | 1.73 |
Interest Coverage | 5,189.00 | 6.63 | 10.47 |
Quick Ratio
DIVISLAB
TORNTPHARM
533573
Profitability
|
Metric
|
DIVISLAB
|
TORNTPHARM
|
533573
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
DIVISLAB
TORNTPHARM
533573
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Htzvpbrmq | Bqt | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Pmfbxzmq | Jqgqh | $70.8 Bil | |
HLN
| Haleon PLC ADR | Hqjzbsq | Fhdgv | $38.2 Bil | |
VTRS
| Viatris Inc | Xpvjtvyf | Fln | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wlggyzwym | Gcff | $12.5 Bil | |
CTLT
| Catalent Inc | Kmljdllhb | Yvhdk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dnbjxrgr | Jtrfx | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Qbmbxydl | Vqcg | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yybtpyjn | Mskqqd | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Txsrhxdk | Wzctx | $2.9 Bil |